Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro

Endocrinology

Volumn 140, Issue 11, 1999, Pages 5339-5347

  Gohel, Anita ^a   McCarthy, Mary Beth ^a   Gronowicz, Gloria ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; ESTRADIOL; ESTROGEN; GLUCOCORTICOID;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CALVARIA; CONTROLLED STUDY; DNA DEGRADATION; ESTROGEN ACTIVITY; NEWBORN; NICK END LABELING; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 0033303829     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.11.7135     Document Type: Article

References (58)

1. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases
2. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis
3. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content
4. Corticosteroid effects on proximal femur bone loss
5. Steroid-induced fractures and bone loss in patients with asthma
6. Cushing's syndrome-killing disease: Discriminatory value of signs and symptoms aiding early diagnosis
7. Vertebral fractures resulting from prolonged cortisone and cortcotrophin therapy
8. Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis
9. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment
10. Menopausal changes in bone remodeling
11. Glucocorticoid-induced osteoporosis: Pathogenesis and management
12. Premenopausal bone loss - A risk factor for osteoporosis
13. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy
14. Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro
15. Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae
16. Glucocorticoids inhibit fibronectin synthesis and messenger ribonucleic acid levels in cultured fetal rat parietal bones
17. Mechanisms of glucocorticoid action in bone cells
18. Direct modulation of osteoblastic activity with estrogen
19. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
20. Estrogens and the skeleton: Cellular and molecular mechanisms
21. Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving β-estradiol
22. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3
23. Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect
24. Skeletal response to corticosteroid deficiency and excess in growing male rats
25. Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats
26. Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse
27. Retardation of bone growth in triamcinolone-treated mice
28. Glucocorticoids cause apoptosis in osteoblasts in vitro and in vivo
29. Glucocorticoids induce apoptosis in osteoblasts by the regulation of Bcl-2, Bax and other cell cycle factors
30. Inhibition of osteoblastogenesis and promotion of apoptotis by osteoblasts and osteocytes by gluccorticoids
31. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system
32. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis
33. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-α production in SLE but not in normal cultures
34. Estrogen inhibits bone resorption by directly inducing apoptosis of bone resorbing osteoclasts
35. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
36. Cytoplasmic glucocorticoid binding proteins in bone cells
37. Evidence of estrogen receptors in normal human osteoblast-like cells
38. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells
39. Bcl-2 and the regulation of programmed cell death
40. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma
41. Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells
42. Regulators of cell death
43. Target cells in bone for parathormone and calcitonin are different: Enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces
44. Further biochemical and molecular characterization of primary rat parietal bone cell cultures
45. Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice
46. 1 integrin expression
47. Immunogold localization of β1 integrins in bone: Effect of glucocorticoids and insulin-like growth factor I on integrins and osteocytes
48. 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression
49. Identification of dying cells-in situ staining
50. Bcl-2 expression in adult and embryonic non-haematopoietic tissues
51. Apoptosis. A sticky business
52. The Bcl-2 protein family: Arbiters of cell survival
53. Prevention of programmed cell death of sympathetic neurons by bcl-2 proto-oncogene
54. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid
55. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
56. Long-term replacement therapy prevents bone loss and fractures
57. Apoptosis and steroid hormones